fanta.bio Sample: CNhs10629
18564 enriched TFs, sorted by log₁₀ q-value (most significant first).
| TF | Cell Type | Active overlap | Inactive overlap | log₁₀ p-value | log₁₀ q-value | Fold-enrichment |
|---|---|---|---|---|---|---|
| HIF1A SRX11007095 | HK-2 Kidney | 1959 / 16536 (11.8%) | 1011 / 165360 (0.6%) | −324.0 | −324.0 | 19.38 |
| TP53 SRX1547996 | Dermal fibroblast Epidermis | 904 / 16536 (5.5%) | 515 / 165360 (0.3%) | −324.0 | −324.0 | 17.55 |
| DVL1 SRX22740968 | MDA-MB-231 Breast | 1402 / 16536 (8.5%) | 852 / 165360 (0.5%) | −324.0 | −324.0 | 16.46 |
| DVL1 SRX22740970 | MDA-MB-231 Breast | 1919 / 16536 (11.6%) | 1239 / 165360 (0.7%) | −324.0 | −324.0 | 15.49 |
| DVL1 SRX22740969 | MDA-MB-231 Breast | 1984 / 16536 (12.0%) | 1283 / 165360 (0.8%) | −324.0 | −324.0 | 15.46 |
| SCML2 SRX644728 | 293 Kidney | 1194 / 16536 (7.2%) | 800 / 165360 (0.5%) | −324.0 | −324.0 | 14.93 |
| TP53 SRX1547998 | Dermal fibroblast Epidermis | 1301 / 16536 (7.9%) | 892 / 165360 (0.5%) | −324.0 | −324.0 | 14.59 |
| MED1 SRX9419944 | BT-474 Breast | 3151 / 16536 (19.1%) | 2893 / 165360 (1.7%) | −324.0 | −324.0 | 10.89 |
| BRD4 SRX9419937 | BT-474 Breast | 3212 / 16536 (19.4%) | 2953 / 165360 (1.8%) | −324.0 | −324.0 | 10.88 |
| MED1 SRX9419945 | BT-474 Breast | 3190 / 16536 (19.3%) | 2942 / 165360 (1.8%) | −324.0 | −324.0 | 10.84 |
| MED1 SRX9419947 | BT-474 Breast | 3257 / 16536 (19.7%) | 3004 / 165360 (1.8%) | −324.0 | −324.0 | 10.84 |
| FOXP1 SRX736067 | LNCAP Prostate | 1406 / 16536 (8.5%) | 1322 / 165360 (0.8%) | −324.0 | −324.0 | 10.64 |
| BRD4 SRX9419935 | BT-474 Breast | 3134 / 16536 (19.0%) | 2947 / 165360 (1.8%) | −324.0 | −324.0 | 10.63 |
| BRD4 SRX9419936 | BT-474 Breast | 3246 / 16536 (19.6%) | 3070 / 165360 (1.9%) | −324.0 | −324.0 | 10.57 |
| MYH11 SRX265221 | ME-1 Blood | 702 / 16536 (4.2%) | 678 / 165360 (0.4%) | −324.0 | −324.0 | 10.35 |
| BRD4 SRX9419938 | BT-474 Breast | 3206 / 16536 (19.4%) | 3099 / 165360 (1.9%) | −324.0 | −324.0 | 10.35 |
| MED1 SRX9419946 | BT-474 Breast | 3230 / 16536 (19.5%) | 3141 / 165360 (1.9%) | −324.0 | −324.0 | 10.28 |
| EZH2 SRX2146136 | LNCAP Prostate | 6937 / 16536 (42.0%) | 8334 / 165360 (5.0%) | −324.0 | −324.0 | 8.32 |
| BRD4 SRX736201 | 90-8TL Neural | 4894 / 16536 (29.6%) | 6979 / 165360 (4.2%) | −324.0 | −324.0 | 7.01 |
| Epitope tags SRX20419389 | Keratinocytes Epidermis | 1555 / 16536 (9.4%) | 2780 / 165360 (1.7%) | −324.0 | −324.0 | 5.59 |
| HMGB1 SRX2765964 | HUVEC Cardiovascular | 1929 / 16536 (11.7%) | 4834 / 165360 (2.9%) | −324.0 | −324.0 | 3.99 |
| AGO2 SRX4708039 | Hep G2 Liver | 2049 / 16536 (12.4%) | 7273 / 165360 (4.4%) | −324.0 | −324.0 | 2.82 |
| EED SRX8175103 | ES cells Pluripotent stem cell | 2425 / 16536 (14.7%) | 9326 / 165360 (5.6%) | −324.0 | −324.0 | 2.60 |
| RUNX1 SRX2513054 | 293 Kidney | 3733 / 16536 (22.6%) | 17164 / 165360 (10.4%) | −324.0 | −324.0 | 2.17 |
| PBX4 SRX2731658 | PC-3 Prostate | 810 / 16536 (4.9%) | 25970 / 165360 (15.7%) | −324.0 | −324.0 | 0.31 |
| YAP1 SRX757325 | H2052 Lung | 478 / 16536 (2.9%) | 20197 / 165360 (12.2%) | −324.0 | −324.0 | 0.24 |
| YAP1 SRX757326 | H2052 Lung | 402 / 16536 (2.4%) | 18129 / 165360 (11.0%) | −324.0 | −324.0 | 0.22 |
| HMGB1 SRX10567335 | HUVEC Cardiovascular | 1659 / 16536 (10.0%) | 5158 / 165360 (3.1%) | −316.6 | −313.5 | 3.22 |
| CHD1 SRX2268291 | Mesenchymal stem cells Others | 1360 / 16536 (8.2%) | 3612 / 165360 (2.2%) | −313.1 | −310.0 | 3.77 |
| FOS SRX150477 | MCF 10A Breast | 545 / 16536 (3.3%) | 19405 / 165360 (11.7%) | −312.0 | −309.0 | 0.28 |
| HIF1A SRX20663235 | HK-2 Kidney | 493 / 16536 (3.0%) | 274 / 165360 (0.2%) | −311.7 | −308.7 | 17.99 |
| CIC SRX13262055 | Astrocytes Neural | 3332 / 16536 (20.1%) | 16107 / 165360 (9.7%) | −311.7 | −308.6 | 2.07 |
| FOS SRX150478 | MCF 10A Breast | 572 / 16536 (3.5%) | 19839 / 165360 (12.0%) | −311.4 | −308.4 | 0.29 |
| 5-mC SRX882970 | LNCAP Prostate | 3123 / 16536 (18.9%) | 14682 / 165360 (8.9%) | −308.4 | −305.5 | 2.13 |
| 5-mC SRX882968 | LNCAP Prostate | 3089 / 16536 (18.7%) | 14582 / 165360 (8.8%) | −301.9 | −298.9 | 2.12 |
| TRP47 SRX4548329 | THP-1 Blood | 2862 / 16536 (17.3%) | 13467 / 165360 (8.1%) | −279.1 | −276.1 | 2.13 |
| EED SRX8175102 | ES cells Pluripotent stem cell | 1955 / 16536 (11.8%) | 7463 / 165360 (4.5%) | −276.2 | −273.3 | 2.62 |
| JUN SRX11051031 | hTERT RPE-1 Neural | 898 / 16536 (5.4%) | 23804 / 165360 (14.4%) | −275.9 | −273.0 | 0.38 |
| FOS SRX4192880 | MCF 10A Breast | 402 / 16536 (2.4%) | 15718 / 165360 (9.5%) | −271.3 | −268.4 | 0.26 |
| 5-mC SRX882965 | LNCAP Prostate | 2518 / 16536 (15.2%) | 11347 / 165360 (6.9%) | −265.7 | −262.8 | 2.22 |
| BMI1 SRX7196715 | SU-DIPG-IV Neural | 2034 / 16536 (12.3%) | 8152 / 165360 (4.9%) | −264.8 | −261.9 | 2.50 |
| SREBF2 SRX5359048 | HCC70 Breast | 1897 / 16536 (11.5%) | 7293 / 165360 (4.4%) | −264.4 | −261.5 | 2.60 |
| CNOT3 SRX886405 | HCT 116 Digestive tract | 2118 / 16536 (12.8%) | 8706 / 165360 (5.3%) | −264.1 | −261.2 | 2.43 |
| JUN SRX11051032 | hTERT RPE-1 Neural | 921 / 16536 (5.6%) | 23578 / 165360 (14.3%) | −259.6 | −256.7 | 0.39 |
| GATA3 SRX190194 | SK-N-SH Neural | 635 / 16536 (3.8%) | 19083 / 165360 (11.5%) | −255.0 | −252.1 | 0.33 |
| ERG SRX026653 | CD34 Hematopoietic stem cells Blood | 1806 / 16536 (10.9%) | 6927 / 165360 (4.2%) | −251.9 | −249.1 | 2.61 |
| FOXA2 SRX4677296 | CFPAC-1 Pancreas | 595 / 16536 (3.6%) | 18342 / 165360 (11.1%) | −251.8 | −248.9 | 0.32 |
| TRIM25 SRX1660873 | Breast cancer cells Breast | 2104 / 16536 (12.7%) | 8878 / 165360 (5.4%) | −249.6 | −246.7 | 2.37 |
| RUNX1 SRX2014504 | Jurkat Blood | 2600 / 16536 (15.7%) | 12339 / 165360 (7.5%) | −245.9 | −243.1 | 2.11 |
| SS18 SRX3468047 | Fibroblasts Others | 700 / 16536 (4.2%) | 19779 / 165360 (12.0%) | −245.4 | −242.6 | 0.35 |
| Epitope tags SRX10549776 | K-562 Blood | 1471 / 16536 (8.9%) | 5013 / 165360 (3.0%) | −245.1 | −242.3 | 2.93 |
| BMI1 SRX7196721 | SF8628 Neural | 1874 / 16536 (11.3%) | 7532 / 165360 (4.6%) | −241.4 | −238.6 | 2.49 |
| MEAF6 SRX10606584 | GIST-T1 Digestive tract | 1730 / 16536 (10.5%) | 6641 / 165360 (4.0%) | −240.2 | −237.4 | 2.61 |
| MECOM SRX23677884 | HNT-34 Blood | 1895 / 16536 (11.5%) | 7699 / 165360 (4.7%) | −239.5 | −236.7 | 2.46 |
| CHD1 SRX2268290 | Mesenchymal stem cells Others | 617 / 16536 (3.7%) | 903 / 165360 (0.5%) | −239.1 | −236.3 | 6.83 |
| CDYL2 SRX8321653 | MCF-7 Breast | 1973 / 16536 (11.9%) | 8263 / 165360 (5.0%) | −236.3 | −233.5 | 2.39 |
| PTEN SRX5416007 | SMMC-7721 Liver | 1952 / 16536 (11.8%) | 8138 / 165360 (4.9%) | −235.6 | −232.9 | 2.40 |
| SMARCC1 SRX11379507 | Liposarcoma, Myxoid Adipocyte | 584 / 16536 (3.5%) | 17636 / 165360 (10.7%) | −235.5 | −232.8 | 0.33 |
| CHD1 SRX2268289 | Mesenchymal stem cells Others | 620 / 16536 (3.7%) | 940 / 165360 (0.6%) | −234.3 | −231.5 | 6.60 |
| JUN SRX17561461 | LPS141 Adipocyte | 373 / 16536 (2.3%) | 14088 / 165360 (8.5%) | −234.2 | −231.4 | 0.26 |
| MECOM SRX23677896 | HNT-34 Blood | 2267 / 16536 (13.7%) | 10316 / 165360 (6.2%) | −232.1 | −229.4 | 2.20 |
| MECOM SRX23677897 | HNT-34 Blood | 2194 / 16536 (13.3%) | 9844 / 165360 (6.0%) | −230.7 | −228.0 | 2.23 |
| JUN SRX11051045 | hTERT RPE-1 Neural | 941 / 16536 (5.7%) | 22839 / 165360 (13.8%) | −230.6 | −227.8 | 0.41 |
| FOS SRX150517 | MCF 10A Breast | 476 / 16536 (2.9%) | 15713 / 165360 (9.5%) | −230.1 | −227.4 | 0.30 |
| AGO2 SRX6783958 | Hep G2 Liver | 1310 / 16536 (7.9%) | 4300 / 165360 (2.6%) | −229.5 | −226.8 | 3.05 |
| MECOM SRX23677885 | HNT-34 Blood | 1888 / 16536 (11.4%) | 7864 / 165360 (4.8%) | −227.7 | −225.0 | 2.40 |
| SMARCA2 SRX8119677 | MeT-5A Others | 451 / 16536 (2.7%) | 15207 / 165360 (9.2%) | −227.2 | −224.5 | 0.30 |
| FOXA1 SRX4815198 | MCF-7 Breast | 1011 / 16536 (6.1%) | 23680 / 165360 (14.3%) | −226.2 | −223.5 | 0.43 |
| TCF12 SRX190356 | SK-N-SH Neural | 808 / 16536 (4.9%) | 20715 / 165360 (12.5%) | −225.4 | −222.7 | 0.39 |
| AGO2 SRX6783957 | Hep G2 Liver | 1315 / 16536 (8.0%) | 4411 / 165360 (2.7%) | −223.3 | −220.6 | 2.98 |
| FOS SRX150476 | MCF 10A Breast | 492 / 16536 (3.0%) | 15730 / 165360 (9.5%) | −222.5 | −219.9 | 0.31 |
| EP300 SRX2671813 | Fibroblasts Others | 185 / 16536 (1.1%) | 10226 / 165360 (6.2%) | −222.5 | −219.8 | 0.18 |
| DNMT3B SRX3275107 | iPS cells Pluripotent stem cell | 606 / 16536 (3.7%) | 967 / 165360 (0.6%) | −220.5 | −217.8 | 6.27 |
| WDR5 SRX5416008 | SMMC-7721 Liver | 1910 / 16536 (11.6%) | 8146 / 165360 (4.9%) | −220.3 | −217.6 | 2.34 |
| JUNB SRX8488073 | SUM 229PE Breast | 532 / 16536 (3.2%) | 16302 / 165360 (9.9%) | −220.1 | −217.5 | 0.33 |
| MITF SRX1555436 | 501A Epidermis | 2056 / 16536 (12.4%) | 9170 / 165360 (5.5%) | −217.8 | −215.2 | 2.24 |
| SMARCA2 SRX8119674 | MRC-5 Lung | 719 / 16536 (4.3%) | 18969 / 165360 (11.5%) | −213.4 | −210.8 | 0.38 |
| JUN SRX11051046 | hTERT RPE-1 Neural | 876 / 16536 (5.3%) | 21225 / 165360 (12.8%) | −212.0 | −209.4 | 0.41 |
| MEAF6 SRX10606585 | GIST-T1 Digestive tract | 1816 / 16536 (11.0%) | 7698 / 165360 (4.7%) | −211.1 | −208.5 | 2.36 |
| FOXA1 SRX176862 | MCF-7 Breast | 389 / 16536 (2.4%) | 13635 / 165360 (8.2%) | −210.5 | −207.9 | 0.29 |
| JUN SRX6582171 | GM07492 Others | 581 / 16536 (3.5%) | 16698 / 165360 (10.1%) | −208.9 | −206.3 | 0.35 |
| ERG SRX063922 | K-562 Blood | 1660 / 16536 (10.0%) | 6750 / 165360 (4.1%) | −207.8 | −205.2 | 2.46 |
| JUNB SRX8488088 | SUM 229PE Breast | 588 / 16536 (3.6%) | 16761 / 165360 (10.1%) | −207.5 | −204.9 | 0.35 |
| ERG SRX063921 | K-562 Blood | 1587 / 16536 (9.6%) | 6295 / 165360 (3.8%) | −207.2 | −204.6 | 2.52 |
| Epitope tags SRX8109066 | Gastric cancer cells Digestive tract | 1968 / 16536 (11.9%) | 8848 / 165360 (5.4%) | −204.4 | −201.8 | 2.22 |
| FOXA2 SRX5504125 | CFPAC-1 Pancreas | 368 / 16536 (2.2%) | 13070 / 165360 (7.9%) | −204.0 | −201.4 | 0.28 |
| NANOG SRX3288566 | hESC H9 Pluripotent stem cell | 206 / 16536 (1.2%) | 10102 / 165360 (6.1%) | −203.3 | −200.7 | 0.20 |
| ESR1 SRX371478 | MCF-7 Breast | 394 / 16536 (2.4%) | 13484 / 165360 (8.2%) | −203.2 | −200.6 | 0.29 |
| ZFX SRX7805372 | 293 Kidney | 1626 / 16536 (9.8%) | 6617 / 165360 (4.0%) | −202.8 | −200.3 | 2.46 |
| TP53 SRX19538279 | Osteoblasts Bone | 377 / 16536 (2.3%) | 313 / 165360 (0.2%) | −202.1 | −199.5 | 12.04 |
| PRRX1 SRX15235713 | Hs 578T Breast | 346 / 16536 (2.1%) | 12607 / 165360 (7.6%) | −201.4 | −198.9 | 0.27 |
| JUNB SRX10119396 | MDA-MB-231 Breast | 284 / 16536 (1.7%) | 11488 / 165360 (6.9%) | −200.6 | −198.1 | 0.25 |
| CTNNB1 SRX13991431 | MCF 10A Breast | 351 / 16536 (2.1%) | 254 / 165360 (0.2%) | −200.0 | −197.5 | 13.82 |
| GATA3 SRX190239 | MCF-7 Breast | 462 / 16536 (2.8%) | 14500 / 165360 (8.8%) | −199.8 | −197.2 | 0.32 |
| BRD1 SRX286203 | RKO Digestive tract | 1191 / 16536 (7.2%) | 4034 / 165360 (2.4%) | −198.4 | −195.9 | 2.95 |
| BRPF3 SRX796085 | RKO Digestive tract | 1100 / 16536 (6.7%) | 3525 / 165360 (2.1%) | −198.2 | −195.7 | 3.12 |
| RORC SRX5359052 | HCC70 Breast | 1368 / 16536 (8.3%) | 5092 / 165360 (3.1%) | −197.9 | −195.4 | 2.69 |
| RELA SRX2207673 | HUVEC Cardiovascular | 1177 / 16536 (7.1%) | 24877 / 165360 (15.0%) | −197.5 | −195.0 | 0.47 |
| TRIM25 SRX1660872 | Breast cancer cells Breast | 1716 / 16536 (10.4%) | 7303 / 165360 (4.4%) | −197.2 | −194.7 | 2.35 |
| FOXA1 SRX176863 | MCF-7 Breast | 376 / 16536 (2.3%) | 12970 / 165360 (7.8%) | −196.7 | −194.1 | 0.29 |
| ESR1 SRX4367193 | MCF-7 Breast | 1066 / 16536 (6.4%) | 23311 / 165360 (14.1%) | −196.4 | −193.8 | 0.46 |
| FOS SRX4192879 | MCF 10A Breast | 343 / 16536 (2.1%) | 12370 / 165360 (7.5%) | −195.4 | −192.9 | 0.28 |
| ESR1 SRX371469 | MCF-7 Breast | 323 / 16536 (2.0%) | 12011 / 165360 (7.3%) | −195.1 | −192.6 | 0.27 |
| FOSL2 SRX190296 | SK-N-SH Neural | 403 / 16536 (2.4%) | 13370 / 165360 (8.1%) | −194.9 | −192.4 | 0.30 |
| KAT7 SRX101303 | RKO Digestive tract | 1345 / 16536 (8.1%) | 5003 / 165360 (3.0%) | −194.6 | −192.1 | 2.69 |
| FOXA1 SRX4815197 | MCF-7 Breast | 795 / 16536 (4.8%) | 19380 / 165360 (11.7%) | −193.7 | −191.2 | 0.41 |
| KMT2A SRX2323891 | 293 Kidney | 1052 / 16536 (6.4%) | 3320 / 165360 (2.0%) | −193.4 | −190.9 | 3.17 |
| SMARCC1 SRX11379511 | Liposarcoma, Myxoid Adipocyte | 402 / 16536 (2.4%) | 13291 / 165360 (8.0%) | −193.1 | −190.6 | 0.30 |
| SMARCA4 SRX5212366 | Mel270 Others | 407 / 16536 (2.5%) | 13374 / 165360 (8.1%) | −192.9 | −190.5 | 0.30 |
| DOT1L SRX10606581 | GIST-T1 Digestive tract | 2112 / 16536 (12.8%) | 10093 / 165360 (6.1%) | −192.9 | −190.4 | 2.09 |
| TP53 SRX19538274 | U2OS Bone | 322 / 16536 (1.9%) | 208 / 165360 (0.1%) | −192.3 | −189.8 | 15.48 |
| RELA SRX2207672 | HUVEC Cardiovascular | 1274 / 16536 (7.7%) | 25961 / 165360 (15.7%) | −192.2 | −189.7 | 0.49 |
| SMARCA4 SRX5075169 | Neural progenitor cells Neural | 620 / 16536 (3.7%) | 16703 / 165360 (10.1%) | −191.5 | −189.1 | 0.37 |
| SMARCA4 SRX5075176 | Neural progenitor cells Neural | 765 / 16536 (4.6%) | 18840 / 165360 (11.4%) | −190.9 | −188.4 | 0.41 |
| GATA3 SRX176864 | MCF-7 Breast | 213 / 16536 (1.3%) | 9862 / 165360 (6.0%) | −190.3 | −187.9 | 0.22 |
| BRPF3 SRX796084 | RKO Digestive tract | 1486 / 16536 (9.0%) | 5950 / 165360 (3.6%) | −190.2 | −187.7 | 2.50 |
| SMARCA4 SRX5075170 | Neural progenitor cells Neural | 798 / 16536 (4.8%) | 19284 / 165360 (11.7%) | −190.0 | −187.6 | 0.41 |
| VGLL1 SRX24602130 | BT-20 Breast | 306 / 16536 (1.9%) | 11548 / 165360 (7.0%) | −189.8 | −187.3 | 0.26 |
| TET2 SRX1427029 | 293 Kidney | 1350 / 16536 (8.2%) | 5108 / 165360 (3.1%) | −189.7 | −187.3 | 2.64 |
| PBX3 SRX190343 | SK-N-SH Neural | 668 / 16536 (4.0%) | 17352 / 165360 (10.5%) | −189.5 | −187.0 | 0.38 |
| ESR1 SRX7624157 | MCF-7 Breast | 855 / 16536 (5.2%) | 20075 / 165360 (12.1%) | −189.2 | −186.8 | 0.43 |
| JUN SRX6582172 | Fibroblasts Others | 406 / 16536 (2.5%) | 13229 / 165360 (8.0%) | −189.1 | −186.6 | 0.31 |
| FOXA1 SRX3931044 | MCF-7 Breast | 711 / 16536 (4.3%) | 17970 / 165360 (10.9%) | −188.9 | −186.5 | 0.40 |
| FOSL2 SRX5054309 | Neural progenitor cells Neural | 292 / 16536 (1.8%) | 11260 / 165360 (6.8%) | −188.6 | −186.1 | 0.26 |
| JUNB SRX8488074 | SUM 229PE Breast | 404 / 16536 (2.4%) | 13177 / 165360 (8.0%) | −188.5 | −186.1 | 0.31 |
| NCOA3 SRX8949280 | ZR-75-1 Breast | 376 / 16536 (2.3%) | 12711 / 165360 (7.7%) | −188.5 | −186.1 | 0.30 |
| MECOM SRX23677890 | HNT-34 Blood | 1840 / 16536 (11.1%) | 8320 / 165360 (5.0%) | −187.9 | −185.5 | 2.21 |
| JUN SRX883584 | MDA-MB-231 Breast | 494 / 16536 (3.0%) | 14607 / 165360 (8.8%) | −187.5 | −185.1 | 0.34 |
| FOXA2 SRX6441753 | CFPAC-1 Pancreas | 412 / 16536 (2.5%) | 13266 / 165360 (8.0%) | −187.1 | −184.7 | 0.31 |
| JUND SRX190357 | SK-N-SH Neural | 387 / 16536 (2.3%) | 12823 / 165360 (7.8%) | −186.3 | −183.9 | 0.30 |
| FOXA1 SRX1161177 | MCF-7 Breast | 328 / 16536 (2.0%) | 11819 / 165360 (7.1%) | −186.3 | −183.9 | 0.28 |
| FOSL1 SRX14181206 | MSK-PCa3 Prostate | 562 / 16536 (3.4%) | 15614 / 165360 (9.4%) | −185.9 | −183.5 | 0.36 |
| YAP1 SRX5718140 | 293 Kidney | 557 / 16536 (3.4%) | 15531 / 165360 (9.4%) | −185.7 | −183.3 | 0.36 |
| MEAF6 SRX10606586 | GIST-T1 Digestive tract | 1283 / 16536 (7.8%) | 4766 / 165360 (2.9%) | −185.6 | −183.2 | 2.69 |
| SMARCA4 SRX5212357 | Mel270 Others | 456 / 16536 (2.8%) | 13912 / 165360 (8.4%) | −184.9 | −182.5 | 0.33 |
| ESR1 SRX7624156 | MCF-7 Breast | 532 / 16536 (3.2%) | 15091 / 165360 (9.1%) | −184.2 | −181.8 | 0.35 |
| RORC SRX5359053 | HCC70 Breast | 1292 / 16536 (7.8%) | 4844 / 165360 (2.9%) | −184.2 | −181.8 | 2.67 |
| DNMT3B SRX3275108 | iPS cells Pluripotent stem cell | 463 / 16536 (2.8%) | 651 / 165360 (0.4%) | −184.1 | −181.8 | 7.11 |
| FOSL2 SRX10640866 | SK-MEL-147 Epidermis | 632 / 16536 (3.8%) | 16576 / 165360 (10.0%) | −183.0 | −180.6 | 0.38 |
| SMARCA4 SRX5212362 | Mel270 Others | 564 / 16536 (3.4%) | 15499 / 165360 (9.4%) | −181.7 | −179.3 | 0.36 |
| ESR1 SRX371476 | MCF-7 Breast | 235 / 16536 (1.4%) | 10014 / 165360 (6.1%) | −181.6 | −179.2 | 0.23 |
| BRPF3 SRX796086 | RKO Digestive tract | 1413 / 16536 (8.5%) | 5648 / 165360 (3.4%) | −180.9 | −178.6 | 2.50 |
| TET2 SRX2014505 | Jurkat Blood | 2618 / 16536 (15.8%) | 14098 / 165360 (8.5%) | −180.3 | −177.9 | 1.86 |
| ATF1 SRX11470446 | Mesenchymal stem cells Others | 844 / 16536 (5.1%) | 19572 / 165360 (11.8%) | −180.2 | −177.8 | 0.43 |
| MECOM SRX23677891 | HNT-34 Blood | 1815 / 16536 (11.0%) | 8317 / 165360 (5.0%) | −179.9 | −177.6 | 2.18 |
| JUNB SRX10119386 | MCF 10A Breast | 273 / 16536 (1.7%) | 10651 / 165360 (6.4%) | −179.7 | −177.3 | 0.26 |
| YAP1 SRX10119364 | MCF 10A Breast | 247 / 16536 (1.5%) | 10179 / 165360 (6.2%) | −179.7 | −177.3 | 0.24 |
| AR SRX10820653 | LNCAP Prostate | 303 / 16536 (1.8%) | 200 / 165360 (0.1%) | −179.4 | −177.0 | 15.15 |
| SMARCA4 SRX5212371 | Mel270 Others | 456 / 16536 (2.8%) | 13719 / 165360 (8.3%) | −179.3 | −177.0 | 0.33 |
| FOSL2 SRX3367141 | SK-MEL-147 Epidermis | 452 / 16536 (2.7%) | 13633 / 165360 (8.2%) | −178.7 | −176.3 | 0.33 |
| CEBPB SRX11379528 | Liposarcoma, Myxoid Adipocyte | 763 / 16536 (4.6%) | 18343 / 165360 (11.1%) | −178.4 | −176.0 | 0.42 |
| FOXA1 SRX371481 | MCF-7 Breast | 354 / 16536 (2.1%) | 12009 / 165360 (7.3%) | −178.2 | −175.9 | 0.29 |
| GATA3 SRX5057632 | MCF-7 Breast | 199 / 16536 (1.2%) | 9233 / 165360 (5.6%) | −178.2 | −175.8 | 0.22 |
| AR SRX1067071 | LHSAR Prostate | 673 / 16536 (4.1%) | 17006 / 165360 (10.3%) | −177.9 | −175.6 | 0.40 |
| SMARCC1 SRX11379505 | Liposarcoma, Myxoid Adipocyte | 581 / 16536 (3.5%) | 15620 / 165360 (9.4%) | −177.8 | −175.5 | 0.37 |
| JUNB SRX10119395 | MDA-MB-231 Breast | 285 / 16536 (1.7%) | 10801 / 165360 (6.5%) | −177.7 | −175.4 | 0.26 |
| ESR1 SRX176860 | MCF-7 Breast | 564 / 16536 (3.4%) | 15335 / 165360 (9.3%) | −177.1 | −174.8 | 0.37 |
| FOSL2 SRX10640865 | SK-MEL-147 Epidermis | 645 / 16536 (3.9%) | 16549 / 165360 (10.0%) | −176.8 | −174.5 | 0.39 |
| MEAF6 DRX234811 | 293 Kidney | 1657 / 16536 (10.0%) | 7315 / 165360 (4.4%) | −176.7 | −174.4 | 2.27 |
| TLE3 SRX4815191 | MCF-7 Breast | 323 / 16536 (2.0%) | 11431 / 165360 (6.9%) | −176.6 | −174.3 | 0.28 |
| FOXA2 SRX6441752 | CFPAC-1 Pancreas | 343 / 16536 (2.1%) | 11768 / 165360 (7.1%) | −176.5 | −174.2 | 0.29 |
| NCOA3 SRX8949281 | ZR-75-1 Breast | 397 / 16536 (2.4%) | 12669 / 165360 (7.7%) | −176.5 | −174.2 | 0.31 |
| JUNB SRX4192882 | MCF 10A Breast | 237 / 16536 (1.4%) | 9890 / 165360 (6.0%) | −176.3 | −174.0 | 0.24 |
| SMARCC1 SRX11379517 | Liposarcoma, Myxoid Adipocyte | 255 / 16536 (1.5%) | 10192 / 165360 (6.2%) | −175.4 | −173.1 | 0.25 |
| TP53 SRX19538268 | U2OS Bone | 303 / 16536 (1.8%) | 213 / 165360 (0.1%) | −174.8 | −172.5 | 14.23 |
| FOXA1 SRX9419950 | SK-BR-3 Breast | 588 / 16536 (3.6%) | 15613 / 165360 (9.4%) | −174.5 | −172.2 | 0.38 |
| FOSL2 SRX10640867 | SK-MEL-147 Epidermis | 575 / 16536 (3.5%) | 15388 / 165360 (9.3%) | −173.9 | −171.6 | 0.37 |
| FOXA1 SRX1161173 | MCF-7 Breast | 262 / 16536 (1.6%) | 10268 / 165360 (6.2%) | −173.8 | −171.5 | 0.26 |
| RAC1 SRX10365541 | MCF-7 Breast | 163 / 16536 (1.0%) | 8363 / 165360 (5.1%) | −172.4 | −170.1 | 0.19 |
| MAU2 SRX15710550 | Fibroblasts Others | 562 / 16536 (3.4%) | 15137 / 165360 (9.2%) | −172.4 | −170.1 | 0.37 |
| FOXA1 SRX1161176 | MCF-7 Breast | 328 / 16536 (2.0%) | 11373 / 165360 (6.9%) | −172.3 | −170.0 | 0.29 |
| FOXA2 SRX6441750 | CFPAC-1 Pancreas | 288 / 16536 (1.7%) | 10681 / 165360 (6.5%) | −172.3 | −170.0 | 0.27 |
| FOXA1 SRX6441747 | CFPAC-1 Pancreas | 301 / 16536 (1.8%) | 10900 / 165360 (6.6%) | −172.0 | −169.7 | 0.28 |
| FOXA1 SRX371483 | MCF-7 Breast | 393 / 16536 (2.4%) | 12450 / 165360 (7.5%) | −171.9 | −169.6 | 0.32 |
| EP300 SRX2671792 | Cardiac progenitor cells Cardiovascular | 230 / 16536 (1.4%) | 9628 / 165360 (5.8%) | −171.8 | −169.5 | 0.24 |
| GRHL3 SRX2582162 | NHEK Epidermis | 1077 / 16536 (6.5%) | 3753 / 165360 (2.3%) | −171.6 | −169.3 | 2.87 |
| SMARCC1 SRX11379504 | Liposarcoma, Myxoid Adipocyte | 999 / 16536 (6.0%) | 21389 / 165360 (12.9%) | −171.2 | −168.9 | 0.47 |
| ESR1 SRX371470 | ZR-75-1 Breast | 315 / 16536 (1.9%) | 11114 / 165360 (6.7%) | −171.1 | −168.8 | 0.28 |
| FOXA1 SRX1161175 | MCF-7 Breast | 247 / 16536 (1.5%) | 9911 / 165360 (6.0%) | −170.9 | −168.7 | 0.25 |
| JUN SRX4192884 | MCF 10A Breast | 266 / 16536 (1.6%) | 10246 / 165360 (6.2%) | −170.7 | −168.4 | 0.26 |
| TP53 SRX2585782 | MDA-MB-231 Breast | 625 / 16536 (3.8%) | 16029 / 165360 (9.7%) | −170.6 | −168.4 | 0.39 |
| FOXA1 SRX371482 | MCF-7 Breast | 510 / 16536 (3.1%) | 14266 / 165360 (8.6%) | −170.3 | −168.1 | 0.36 |
| CHD6 SRX17709200 | C4-2 Prostate | 1563 / 16536 (9.5%) | 6818 / 165360 (4.1%) | −170.2 | −167.9 | 2.29 |
| ESR1 SRX371479 | MCF-7 Breast | 324 / 16536 (2.0%) | 11233 / 165360 (6.8%) | −169.9 | −167.7 | 0.29 |
| TP53 SRX19538280 | Osteoblasts Bone | 309 / 16536 (1.9%) | 243 / 165360 (0.1%) | −169.8 | −167.5 | 12.72 |
| NCOA3 SRX8949279 | ZR-75-1 Breast | 510 / 16536 (3.1%) | 14224 / 165360 (8.6%) | −169.3 | −167.0 | 0.36 |
| MEAF6 DRX300417 | 293 Kidney | 1508 / 16536 (9.1%) | 6481 / 165360 (3.9%) | −168.9 | −166.7 | 2.33 |
| JUN SRX7277180 | GM07492 Others | 261 / 16536 (1.6%) | 10082 / 165360 (6.1%) | −168.3 | −166.1 | 0.26 |
| NR3C1 SRX2609659 | HASM2 Lung | 390 / 16536 (2.4%) | 12283 / 165360 (7.4%) | −168.3 | −166.1 | 0.32 |
| FOXA1 SRX9419949 | SK-BR-3 Breast | 501 / 16536 (3.0%) | 14028 / 165360 (8.5%) | −167.6 | −165.3 | 0.36 |
| ESR1 SRX20282961 | MCF-7 Breast | 454 / 16536 (2.7%) | 13290 / 165360 (8.0%) | −167.6 | −165.3 | 0.34 |
| ESR1 SRX176861 | MCF-7 Breast | 590 / 16536 (3.6%) | 15380 / 165360 (9.3%) | −167.3 | −165.0 | 0.38 |
| JUN SRX9350646 | Melanoma cell line Epidermis | 443 / 16536 (2.7%) | 13078 / 165360 (7.9%) | −166.5 | −164.3 | 0.34 |
| TP53 SRX19538276 | U2OS Bone | 296 / 16536 (1.8%) | 221 / 165360 (0.1%) | −166.5 | −164.2 | 13.39 |
| TP53 SRX19538273 | U2OS Bone | 275 / 16536 (1.7%) | 176 / 165360 (0.1%) | −164.8 | −162.6 | 15.63 |
| Epitope tags SRX10549778 | K-562 Blood | 1100 / 16536 (6.7%) | 3987 / 165360 (2.4%) | −164.8 | −162.6 | 2.76 |
| TP53 SRX19538275 | U2OS Bone | 289 / 16536 (1.7%) | 209 / 165360 (0.1%) | −164.8 | −162.5 | 13.83 |
| FOXA1 SRX6441749 | CFPAC-1 Pancreas | 308 / 16536 (1.9%) | 10790 / 165360 (6.5%) | −164.7 | −162.5 | 0.29 |
| JUN SRX6582163 | BJ-5ta Epidermis | 428 / 16536 (2.6%) | 12763 / 165360 (7.7%) | −164.4 | −162.2 | 0.34 |
| CHD6 SRX17709201 | C4-2 Prostate | 1505 / 16536 (9.1%) | 6551 / 165360 (4.0%) | −164.4 | −162.1 | 2.30 |
| ZFX SRX7805370 | 293 Kidney | 1151 / 16536 (7.0%) | 4306 / 165360 (2.6%) | −164.0 | −161.8 | 2.67 |
| ESR1 SRX371467 | MCF-7 Breast | 381 / 16536 (2.3%) | 11949 / 165360 (7.2%) | −162.8 | −160.6 | 0.32 |
| TEAD1 SRX3401272 | MCF-7 Breast | 250 / 16536 (1.5%) | 9710 / 165360 (5.9%) | −162.7 | −160.5 | 0.26 |
| FOXL2 SRX6957431 | KGN Gonad | 806 / 16536 (4.9%) | 18353 / 165360 (11.1%) | −162.5 | −160.3 | 0.44 |
| YAP1 SRX1038945 | IMR-90 Lung | 244 / 16536 (1.5%) | 9594 / 165360 (5.8%) | −162.4 | −160.2 | 0.25 |
| ESR1 SRX20282960 | MCF-7 Breast | 416 / 16536 (2.5%) | 12499 / 165360 (7.6%) | −162.3 | −160.1 | 0.33 |
| JUNB SRX8488089 | SUM 229PE Breast | 341 / 16536 (2.1%) | 11269 / 165360 (6.8%) | −162.2 | −160.0 | 0.30 |
| JUN SRX2355072 | HAEC Cardiovascular | 447 / 16536 (2.7%) | 12995 / 165360 (7.9%) | −162.2 | −160.0 | 0.34 |
| CEBPB SRX150632 | HeLa Uterus | 810 / 16536 (4.9%) | 18381 / 165360 (11.1%) | −161.8 | −159.6 | 0.44 |
| SMARCC1 SRX11379506 | Liposarcoma, Myxoid Adipocyte | 601 / 16536 (3.6%) | 15316 / 165360 (9.3%) | −161.1 | −158.9 | 0.39 |
| ESR1 SRX371471 | ZR-75-1 Breast | 399 / 16536 (2.4%) | 12176 / 165360 (7.4%) | −160.8 | −158.6 | 0.33 |
| FOXA2 SRX6441755 | CFPAC-1 Pancreas | 256 / 16536 (1.5%) | 9759 / 165360 (5.9%) | −160.7 | −158.5 | 0.26 |
| LEO1 SRX1873456 | SEM Blood | 1399 / 16536 (8.5%) | 5937 / 165360 (3.6%) | −160.1 | −157.9 | 2.36 |
| Epitope tags SRX2867680 | 293 Kidney | 2016 / 16536 (12.2%) | 10205 / 165360 (6.2%) | −159.6 | −157.4 | 1.98 |
| ESR1 SRX1531791 | MCF-7 Breast | 353 / 16536 (2.1%) | 11375 / 165360 (6.9%) | −159.4 | −157.2 | 0.31 |
| ESR1 SRX194569 | MCF-7 Breast | 387 / 16536 (2.3%) | 11935 / 165360 (7.2%) | −159.4 | −157.2 | 0.32 |
| AR SRX1067070 | LHSAR Prostate | 888 / 16536 (5.4%) | 19360 / 165360 (11.7%) | −159.0 | −156.8 | 0.46 |
| FOXA1 SRX1787653 | MCF-7 Breast | 285 / 16536 (1.7%) | 10200 / 165360 (6.2%) | −158.6 | −156.4 | 0.28 |
| IRF3 SRX11453858 | Hep G2 Liver | 232 / 16536 (1.4%) | 102 / 165360 (0.1%) | −158.5 | −156.3 | 22.75 |
| ARID1A SRX5679787 | 12Z Others | 114 / 16536 (0.7%) | 6952 / 165360 (4.2%) | −158.3 | −156.1 | 0.16 |
| RAC1 SRX10365543 | MCF-7 Breast | 184 / 16536 (1.1%) | 8350 / 165360 (5.0%) | −158.0 | −155.8 | 0.22 |
| FOXA1 SRX8537740 | SUM 44PE Breast | 796 / 16536 (4.8%) | 18013 / 165360 (10.9%) | −157.5 | −155.3 | 0.44 |
| TP53 SRX19538267 | U2OS Bone | 271 / 16536 (1.6%) | 188 / 165360 (0.1%) | −157.3 | −155.1 | 14.41 |
| CXXC1 SRX1424886 | SEM Blood | 1404 / 16536 (8.5%) | 6030 / 165360 (3.6%) | −156.9 | −154.8 | 2.33 |
| YAP1 SRX10119388 | MDA-MB-231 Breast | 229 / 16536 (1.4%) | 9153 / 165360 (5.5%) | −156.8 | −154.6 | 0.25 |
| FOXA1 SRX1389381 | CFPAC-1 Pancreas | 304 / 16536 (1.8%) | 10466 / 165360 (6.3%) | −156.8 | −154.6 | 0.29 |
| ESR2 SRX8272750 | HT-29 Digestive tract | 498 / 16536 (3.0%) | 950 / 165360 (0.6%) | −156.7 | −154.6 | 5.24 |
| FOXA1 SRX1161174 | MCF-7 Breast | 373 / 16536 (2.3%) | 11614 / 165360 (7.0%) | −156.7 | −154.5 | 0.32 |
| TEAD1 SRX716558 | SF268 Neural | 153 / 16536 (0.9%) | 7695 / 165360 (4.7%) | −156.2 | −154.0 | 0.20 |
| TP53 SRX19538281 | Osteoblasts Bone | 327 / 16536 (2.0%) | 341 / 165360 (0.2%) | −156.1 | −154.0 | 9.59 |
| Epitope tags SRX7276677 | 293 Kidney | 2581 / 16536 (15.6%) | 14522 / 165360 (8.8%) | −156.1 | −154.0 | 1.78 |
| NR3C1 SRX2609664 | HASM2 Lung | 506 / 16536 (3.1%) | 13699 / 165360 (8.3%) | −156.1 | −153.9 | 0.37 |
| EP300 SRX150579 | HeLa Uterus | 222 / 16536 (1.3%) | 9003 / 165360 (5.4%) | −156.1 | −153.9 | 0.25 |
| ESR1 SRX371468 | MCF-7 Breast | 234 / 16536 (1.4%) | 9211 / 165360 (5.6%) | −155.9 | −153.8 | 0.25 |
| ARID1A SRX5679788 | 12Z Others | 129 / 16536 (0.8%) | 7191 / 165360 (4.3%) | −155.6 | −153.4 | 0.18 |
| ARID1A SRX5089376 | MCF-7 Breast | 313 / 16536 (1.9%) | 10576 / 165360 (6.4%) | −155.5 | −153.3 | 0.30 |
| FOS SRX070879 | HUVEC Cardiovascular | 369 / 16536 (2.2%) | 11503 / 165360 (7.0%) | −155.3 | −153.2 | 0.32 |
| JUNB SRX10119384 | MCF 10A Breast | 204 / 16536 (1.2%) | 8641 / 165360 (5.2%) | −155.1 | −153.0 | 0.24 |
| NR3C1 SRX2609661 | HASM2 Lung | 394 / 16536 (2.4%) | 11900 / 165360 (7.2%) | −155.0 | −152.9 | 0.33 |
| ESR1 SRX20282939 | MCF-7 Breast | 431 / 16536 (2.6%) | 12484 / 165360 (7.5%) | −154.9 | −152.8 | 0.35 |
| PHF6 SRX11508321 | G-401 Kidney | 1492 / 16536 (9.0%) | 6658 / 165360 (4.0%) | −154.8 | −152.6 | 2.24 |
| ESR1 SRX371477 | MCF-7 Breast | 170 / 16536 (1.0%) | 7982 / 165360 (4.8%) | −154.7 | −152.6 | 0.21 |
| ESR1 SRX194572 | MCF-7 Breast | 232 / 16536 (1.4%) | 9139 / 165360 (5.5%) | −154.7 | −152.6 | 0.25 |
| FOSL2 SRX10640864 | SK-MEL-147 Epidermis | 479 / 16536 (2.9%) | 13226 / 165360 (8.0%) | −154.6 | −152.4 | 0.36 |
| BRPF1 SRX10606575 | GIST-T1 Digestive tract | 663 / 16536 (4.0%) | 1718 / 165360 (1.0%) | −154.5 | −152.3 | 3.86 |
| ESR1 SRX10365536 | MCF-7 Breast | 188 / 16536 (1.1%) | 8317 / 165360 (5.0%) | −154.3 | −152.1 | 0.23 |
| FOXA1 SRX371480 | MCF-7 Breast | 245 / 16536 (1.5%) | 9357 / 165360 (5.7%) | −154.3 | −152.1 | 0.26 |
| ING5 SRX286202 | RKO Digestive tract | 1242 / 16536 (7.5%) | 5049 / 165360 (3.1%) | −153.3 | −151.2 | 2.46 |
| ATF1 SRX11470450 | Mesenchymal stem cells Others | 700 / 16536 (4.2%) | 16477 / 165360 (10.0%) | −153.3 | −151.2 | 0.42 |
| JUNB SRX10119383 | MCF 10A Breast | 236 / 16536 (1.4%) | 9158 / 165360 (5.5%) | −153.0 | −150.9 | 0.26 |
| KMT2A SRX2281249 | SEM Blood | 1868 / 16536 (11.3%) | 9308 / 165360 (5.6%) | −153.0 | −150.8 | 2.01 |
| SMARCA4 SRX5075175 | Neural progenitor cells Neural | 543 / 16536 (3.3%) | 14143 / 165360 (8.6%) | −152.8 | −150.7 | 0.38 |
| JUND SRX699738 | HCASMC Cardiovascular | 495 / 16536 (3.0%) | 13403 / 165360 (8.1%) | −152.5 | −150.4 | 0.37 |
| TAZ SRX14181208 | MSK-PCa3 Prostate | 383 / 16536 (2.3%) | 11619 / 165360 (7.0%) | −152.1 | −150.0 | 0.33 |
| DNA-RNA hybrid SRX21658478 | U2OS Bone | 582 / 16536 (3.5%) | 1355 / 165360 (0.8%) | −152.0 | −149.9 | 4.30 |
| NANOG SRX5286327 | ES cells Pluripotent stem cell | 246 / 16536 (1.5%) | 9302 / 165360 (5.6%) | −151.8 | −149.7 | 0.26 |
| FOS SRX3322636 | MCF-7 Breast | 221 / 16536 (1.3%) | 8853 / 165360 (5.4%) | −151.8 | −149.7 | 0.25 |
| FOXA1 SRX3923514 | MCF-7 Breast | 374 / 16536 (2.3%) | 11466 / 165360 (6.9%) | −151.8 | −149.7 | 0.33 |
| FOSL2 SRX5054308 | Neural progenitor cells Neural | 246 / 16536 (1.5%) | 9295 / 165360 (5.6%) | −151.7 | −149.6 | 0.26 |
| MethylCap SRX014767 | NB-4 Blood | 1653 / 16536 (10.0%) | 7826 / 165360 (4.7%) | −151.6 | −149.5 | 2.11 |
| SREBF2 SRX5359049 | HCC70 Breast | 1166 / 16536 (7.1%) | 4605 / 165360 (2.8%) | −151.5 | −149.4 | 2.53 |
| FOXA2 SRX6441754 | CFPAC-1 Pancreas | 260 / 16536 (1.6%) | 9526 / 165360 (5.8%) | −151.2 | −149.1 | 0.27 |
| MAML1 SRX8970969 | Squamous cell carcinoma Others | 348 / 16536 (2.1%) | 11012 / 165360 (6.7%) | −151.0 | −148.9 | 0.32 |
| KAT6A DRX366108 | 293 Kidney | 1652 / 16536 (10.0%) | 7837 / 165360 (4.7%) | −150.8 | −148.7 | 2.11 |
| FOXA1 SRX1161187 | ZR-75-1 Breast | 363 / 16536 (2.2%) | 11251 / 165360 (6.8%) | −150.7 | −148.6 | 0.32 |
| ESR1 SRX2897220 | Breast cancer cells Breast | 1507 / 16536 (9.1%) | 6849 / 165360 (4.1%) | −150.4 | −148.3 | 2.20 |
| YAP1 SRX10119387 | MDA-MB-231 Breast | 254 / 16536 (1.5%) | 9388 / 165360 (5.7%) | −150.1 | −148.0 | 0.27 |
| AR SRX10820651 | LNCAP Prostate | 316 / 16536 (1.9%) | 333 / 165360 (0.2%) | −150.0 | −147.9 | 9.49 |
| CHD7 SRX3581507 | iPS cells Pluripotent stem cell | 287 / 16536 (1.7%) | 9950 / 165360 (6.0%) | −149.7 | −147.7 | 0.29 |
| MYOCD SRX5598318 | A549 Lung | 1647 / 16536 (10.0%) | 7831 / 165360 (4.7%) | −149.4 | −147.4 | 2.10 |
| ESR1 SRX371474 | BT-474 Breast | 162 / 16536 (1.0%) | 7651 / 165360 (4.6%) | −148.7 | −146.7 | 0.21 |
| EP300 SRX2194265 | SUM 159PT Breast | 585 / 16536 (3.5%) | 14611 / 165360 (8.8%) | −148.5 | −146.4 | 0.40 |
| GRHL3 SRX2582161 | NHEK Epidermis | 881 / 16536 (5.3%) | 2947 / 165360 (1.8%) | −148.4 | −146.3 | 2.99 |
| Epitope tags DRX443510 | 293 Kidney | 1374 / 16536 (8.3%) | 6002 / 165360 (3.6%) | −148.3 | −146.2 | 2.29 |
| NR3C1 SRX2609662 | HASM2 Lung | 444 / 16536 (2.7%) | 12453 / 165360 (7.5%) | −148.2 | −146.1 | 0.36 |
| ESR1 SRX20282972 | MCF-7 Breast | 434 / 16536 (2.6%) | 12279 / 165360 (7.4%) | −147.6 | −145.5 | 0.35 |
| SS18 SRX10640842 | SK-MEL-147 Epidermis | 470 / 16536 (2.8%) | 12838 / 165360 (7.8%) | −147.6 | −145.5 | 0.37 |
| EP300 SRX176885 | MCF-7 Breast | 185 / 16536 (1.1%) | 8048 / 165360 (4.9%) | −147.3 | −145.2 | 0.23 |
| DAXX SRX1021630 | PC-3 Prostate | 377 / 16536 (2.3%) | 11353 / 165360 (6.9%) | −147.1 | −145.0 | 0.33 |
| STAT5B SRX831881 | CD8+ T cells Blood | 234 / 16536 (1.4%) | 133 / 165360 (0.1%) | −146.7 | −144.7 | 17.59 |
| WWTR1 SRX10119367 | MCF 10A Breast | 435 / 16536 (2.6%) | 12259 / 165360 (7.4%) | −146.7 | −144.6 | 0.35 |
| FOXA1 SRX825395 | CFPAC-1 Pancreas | 353 / 16536 (2.1%) | 10945 / 165360 (6.6%) | −146.6 | −144.5 | 0.32 |
| BCOR SRX10184493 | K-562 Blood | 2063 / 16536 (12.5%) | 10894 / 165360 (6.6%) | −146.4 | −144.4 | 1.89 |
| RELA SRX5938177 | FaDu Others | 337 / 16536 (2.0%) | 10679 / 165360 (6.5%) | −146.4 | −144.4 | 0.32 |
| FOSL2 SRX190204 | A549 Lung | 355 / 16536 (2.1%) | 10971 / 165360 (6.6%) | −146.4 | −144.3 | 0.32 |
| WWTR1 SRX10119378 | MCF 10A Breast | 401 / 16536 (2.4%) | 11705 / 165360 (7.1%) | −146.2 | −144.1 | 0.34 |
| NKX2-1 SRX2164786 | A549 Lung | 621 / 16536 (3.8%) | 15052 / 165360 (9.1%) | −146.1 | −144.0 | 0.41 |
| STAT3 SRX150479 | MCF 10A Breast | 344 / 16536 (2.1%) | 10778 / 165360 (6.5%) | −146.0 | −144.0 | 0.32 |
| AR SRX1067067 | LHSAR Prostate | 638 / 16536 (3.9%) | 15293 / 165360 (9.2%) | −145.9 | −143.8 | 0.42 |
| NR3C1 SRX2609665 | HASM2 Lung | 415 / 16536 (2.5%) | 11920 / 165360 (7.2%) | −145.9 | −143.8 | 0.35 |
| SS18 SRX10640843 | SK-MEL-147 Epidermis | 574 / 16536 (3.5%) | 14347 / 165360 (8.7%) | −145.8 | −143.8 | 0.40 |
| DNA-RNA hybrid SRX20083260 | SH-SY5Y Neural | 838 / 16536 (5.1%) | 2741 / 165360 (1.7%) | −145.7 | −143.7 | 3.06 |
| Epitope tags SRX2255894 | 293 Kidney | 1294 / 16536 (7.8%) | 5544 / 165360 (3.4%) | −144.9 | −142.8 | 2.33 |
| Epitope tags SRX10715360 | HCB1 Blood | 1089 / 16536 (6.6%) | 4238 / 165360 (2.6%) | −144.8 | −142.8 | 2.57 |
| ARID1A SRX5089379 | MCF-7 Breast | 377 / 16536 (2.3%) | 11270 / 165360 (6.8%) | −144.6 | −142.6 | 0.33 |
| STAT3 SRX150630 | MCF 10A Breast | 344 / 16536 (2.1%) | 10726 / 165360 (6.5%) | −144.5 | −142.4 | 0.32 |
| ARID1A SRX5089385 | MCF-7 Breast | 277 / 16536 (1.7%) | 9593 / 165360 (5.8%) | −144.1 | −142.1 | 0.29 |
| ESR1 SRX10365532 | MCF-7 Breast | 201 / 16536 (1.2%) | 8237 / 165360 (5.0%) | −143.8 | −141.8 | 0.24 |
| FOXA2 SRX5504126 | CFPAC-1 Pancreas | 231 / 16536 (1.4%) | 8774 / 165360 (5.3%) | −143.6 | −141.5 | 0.26 |
| AFF1 SRX2281250 | SEM Blood | 933 / 16536 (5.6%) | 3317 / 165360 (2.0%) | −143.6 | −141.5 | 2.81 |
| MethylCap SRX014766 | NB-4 Blood | 1501 / 16536 (9.1%) | 6956 / 165360 (4.2%) | −143.5 | −141.5 | 2.16 |
| FOXA1 SRX15430994 | SK-BR-3 Breast | 385 / 16536 (2.3%) | 11354 / 165360 (6.9%) | −143.5 | −141.4 | 0.34 |
| JUN SRX6582165 | BJ-5ta Epidermis | 716 / 16536 (4.3%) | 16317 / 165360 (9.9%) | −143.4 | −141.4 | 0.44 |
| FOXA1 SRX1161192 | ZR-75-1 Breast | 354 / 16536 (2.1%) | 10852 / 165360 (6.6%) | −143.4 | −141.3 | 0.33 |
| EP300 SRX100540 | SK-N-SH Neural | 545 / 16536 (3.3%) | 13811 / 165360 (8.4%) | −143.0 | −141.0 | 0.39 |
| DNMT3B SRX2862488 | hESC HUES8 Pluripotent stem cell | 427 / 16536 (2.6%) | 756 / 165360 (0.5%) | −143.0 | −141.0 | 5.65 |
| FOXA1 SRX1787655 | MCF-7 Breast | 182 / 16536 (1.1%) | 7861 / 165360 (4.8%) | −143.0 | −141.0 | 0.23 |
| JUN SRX6582164 | BJ-5ta Epidermis | 477 / 16536 (2.9%) | 12770 / 165360 (7.7%) | −142.8 | −140.7 | 0.37 |
| JUND SRX150408 | HeLa Uterus | 326 / 16536 (2.0%) | 10374 / 165360 (6.3%) | −142.7 | −140.7 | 0.31 |
| ATF3 SRX2207918 | CS1AN Epidermis | 2150 / 16536 (13.0%) | 11648 / 165360 (7.0%) | −142.6 | −140.6 | 1.85 |
| TEAD4 SRX10640862 | SK-MEL-147 Epidermis | 575 / 16536 (3.5%) | 14240 / 165360 (8.6%) | −142.6 | −140.5 | 0.40 |
| GATA3 SRX5457550 | MCF-7 Breast | 430 / 16536 (2.6%) | 12028 / 165360 (7.3%) | −142.3 | −140.2 | 0.36 |
| TLE3 SRX4815192 | MCF-7 Breast | 345 / 16536 (2.1%) | 10666 / 165360 (6.5%) | −142.1 | −140.1 | 0.32 |
| Epitope tags SRX8080565 | Mammary gland adenocarcinoma Breast | 183 / 16536 (1.1%) | 7849 / 165360 (4.7%) | −142.0 | −140.0 | 0.23 |
| FOXA1 SRX9419951 | SK-BR-3 Breast | 503 / 16536 (3.0%) | 13139 / 165360 (7.9%) | −142.0 | −140.0 | 0.38 |
| FOXA1 SRX1161190 | ZR-75-1 Breast | 353 / 16536 (2.1%) | 10782 / 165360 (6.5%) | −141.7 | −139.7 | 0.33 |
| FOXA1 SRX1787652 | MCF-7 Breast | 228 / 16536 (1.4%) | 8661 / 165360 (5.2%) | −141.7 | −139.7 | 0.26 |
| FOXA1 SRX1161189 | ZR-75-1 Breast | 357 / 16536 (2.2%) | 10840 / 165360 (6.6%) | −141.5 | −139.5 | 0.33 |
| ESR1 SRX371475 | BT-474 Breast | 192 / 16536 (1.2%) | 8000 / 165360 (4.8%) | −141.5 | −139.5 | 0.24 |
| ESR1 SRX2943591 | MCF-7 Breast | 271 / 16536 (1.6%) | 9385 / 165360 (5.7%) | −140.9 | −138.9 | 0.29 |
| TAL1 SRX393518 | Primary endothelial cells Cardiovascular | 542 / 16536 (3.3%) | 13688 / 165360 (8.3%) | −140.9 | −138.9 | 0.40 |
| SUZ12 SRX10184494 | K-562 Blood | 2360 / 16536 (14.3%) | 13299 / 165360 (8.0%) | −140.7 | −138.7 | 1.77 |
| EP300 SRX027482 | hESC H9 Pluripotent stem cell | 331 / 16536 (2.0%) | 10384 / 165360 (6.3%) | −140.6 | −138.5 | 0.32 |
| DNA-RNA hybrid SRX20083259 | SH-SY5Y Neural | 757 / 16536 (4.6%) | 2361 / 165360 (1.4%) | −140.4 | −138.4 | 3.21 |
| FOXA1 SRX028634 | MCF-7 Breast | 185 / 16536 (1.1%) | 7832 / 165360 (4.7%) | −140.2 | −138.2 | 0.24 |
| FOS SRX150664 | HUVEC Cardiovascular | 503 / 16536 (3.0%) | 13073 / 165360 (7.9%) | −140.2 | −138.2 | 0.38 |
| FOXA1 SRX11222437 | MCF-7 Breast | 277 / 16536 (1.7%) | 9465 / 165360 (5.7%) | −140.1 | −138.1 | 0.29 |
| INTS3 SRX3640569 | HeLa Uterus | 1198 / 16536 (7.2%) | 5016 / 165360 (3.0%) | −139.7 | −137.7 | 2.39 |
| GATA2 SRX3503584 | Endometrial stromal cells Uterus | 429 / 16536 (2.6%) | 11907 / 165360 (7.2%) | −139.3 | −137.3 | 0.36 |
| ESR1 SRX20282954 | MCF-7 Breast | 440 / 16536 (2.7%) | 12062 / 165360 (7.3%) | −139.0 | −137.0 | 0.36 |
| FOXA1 SRX5203303 | MCF-7 Breast | 123 / 16536 (0.7%) | 6593 / 165360 (4.0%) | −138.9 | −136.9 | 0.19 |
| FOXA1 SRX3931043 | MCF-7 Breast | 401 / 16536 (2.4%) | 11454 / 165360 (6.9%) | −138.9 | −136.9 | 0.35 |
| FOXA1 SRX11222441 | MCF-7 Breast | 299 / 16536 (1.8%) | 9797 / 165360 (5.9%) | −138.9 | −136.9 | 0.31 |
| TFEB SRX6743819 | iPS cells Pluripotent stem cell | 1384 / 16536 (8.4%) | 6265 / 165360 (3.8%) | −138.8 | −136.8 | 2.21 |
| KAT6A DRX366109 | 293 Kidney | 1934 / 16536 (11.7%) | 10160 / 165360 (6.1%) | −138.5 | −136.5 | 1.90 |
| TEAD1 SRX14688734 | HUVEC Cardiovascular | 322 / 16536 (1.9%) | 10161 / 165360 (6.1%) | −138.4 | −136.4 | 0.32 |
| ESR1 SRX10365535 | MCF-7 Breast | 323 / 16536 (2.0%) | 10173 / 165360 (6.2%) | −138.2 | −136.2 | 0.32 |
| FOXA1 SRX5323843 | MCF-7 Breast | 193 / 16536 (1.2%) | 7919 / 165360 (4.8%) | −138.1 | −136.1 | 0.24 |
| FOXA1 SRX100454 | T-47D Breast | 521 / 16536 (3.2%) | 13263 / 165360 (8.0%) | −138.0 | −136.0 | 0.39 |
| NR1H3 SRX1538760 | HT-29 Digestive tract | 368 / 16536 (2.2%) | 10880 / 165360 (6.6%) | −137.6 | −135.6 | 0.34 |
| ESR1 SRX330069 | MCF-7 Breast | 240 / 16536 (1.5%) | 8742 / 165360 (5.3%) | −137.6 | −135.6 | 0.27 |
| TEAD4 SRX10640861 | SK-MEL-147 Epidermis | 412 / 16536 (2.5%) | 11575 / 165360 (7.0%) | −137.4 | −135.5 | 0.36 |
| Epitope tags SRX15725652 | 293 Kidney | 1726 / 16536 (10.4%) | 8678 / 165360 (5.2%) | −137.4 | −135.4 | 1.99 |
| MEN1 SRX11712604 | K-562 Blood | 1322 / 16536 (8.0%) | 5880 / 165360 (3.6%) | −137.3 | −135.3 | 2.25 |
| ESR1 SRX4367192 | MCF-7 Breast | 798 / 16536 (4.8%) | 17224 / 165360 (10.4%) | −137.3 | −135.3 | 0.46 |
| DNA-RNA hybrid SRX20083264 | SH-SY5Y Neural | 689 / 16536 (4.2%) | 2034 / 165360 (1.2%) | −137.3 | −135.3 | 3.39 |
| CEBPB SRX11379527 | Liposarcoma, Myxoid Adipocyte | 689 / 16536 (4.2%) | 15681 / 165360 (9.5%) | −137.1 | −135.1 | 0.44 |
| SMARCA4 SRX8588624 | Pulmonary artery endothelial cells Cardiovascular | 683 / 16536 (4.1%) | 15595 / 165360 (9.4%) | −137.0 | −135.0 | 0.44 |
| FOSL1 SRX2585779 | MDA-MB-231 Breast | 180 / 16536 (1.1%) | 7632 / 165360 (4.6%) | −136.7 | −134.7 | 0.24 |
| FOXA1 SRX1787651 | MCF-7 Breast | 218 / 16536 (1.3%) | 8327 / 165360 (5.0%) | −136.7 | −134.7 | 0.26 |
| DOT1L SRX10606582 | GIST-T1 Digestive tract | 1572 / 16536 (9.5%) | 7605 / 165360 (4.6%) | −136.6 | −134.6 | 2.07 |
| CEBPB SRX150598 | IMR-90 Lung | 788 / 16536 (4.8%) | 17056 / 165360 (10.3%) | −136.5 | −134.6 | 0.46 |
| Epitope tags SRX11470449 | Mesenchymal stem cells Others | 588 / 16536 (3.6%) | 14189 / 165360 (8.6%) | −136.2 | −134.2 | 0.41 |
| STAT3 SRX150536 | MCF 10A Breast | 438 / 16536 (2.6%) | 11918 / 165360 (7.2%) | −135.8 | −133.8 | 0.37 |
| FOXA1 SRX8537741 | SUM 44PE Breast | 655 / 16536 (4.0%) | 15138 / 165360 (9.2%) | −135.7 | −133.7 | 0.43 |
| JUN SRX2355073 | HAEC Cardiovascular | 479 / 16536 (2.9%) | 12543 / 165360 (7.6%) | −135.6 | −133.7 | 0.38 |
| GATA2 SRX16314543 | Trophoblast stem cells Placenta | 349 / 16536 (2.1%) | 10509 / 165360 (6.4%) | −135.6 | −133.7 | 0.33 |
| CARM1 SRX10562203 | MDA-MB-231 Breast | 219 / 16536 (1.3%) | 129 / 165360 (0.1%) | −135.6 | −133.6 | 16.98 |
| FOXA1 SRX3931055 | MCF-7 Breast | 337 / 16536 (2.0%) | 10307 / 165360 (6.2%) | −135.5 | −133.6 | 0.33 |
| SSRP1 SRX3436567 | HT-1080 Bone | 364 / 16536 (2.2%) | 564 / 165360 (0.3%) | −135.1 | −133.2 | 6.45 |
| ESR1 SRX20282946 | MCF-7 Breast | 241 / 16536 (1.5%) | 8674 / 165360 (5.2%) | −135.0 | −133.0 | 0.28 |
| FOXA1 SRX3931054 | MCF-7 Breast | 373 / 16536 (2.3%) | 10866 / 165360 (6.6%) | −134.9 | −132.9 | 0.34 |
| IRF3 SRX11453861 | Hep G2 Liver | 203 / 16536 (1.2%) | 98 / 165360 (0.1%) | −134.7 | −132.7 | 20.71 |
| AR SRX1067066 | LHSAR Prostate | 824 / 16536 (5.0%) | 17476 / 165360 (10.6%) | −134.6 | −132.7 | 0.47 |
| HEXIM1 SRX1177905 | HCT 116 Digestive tract | 1718 / 16536 (10.4%) | 8692 / 165360 (5.3%) | −134.6 | −132.6 | 1.98 |
| CEBPB SRX2194250 | SUM 159PT Breast | 483 / 16536 (2.9%) | 12561 / 165360 (7.6%) | −134.5 | −132.6 | 0.38 |
| FOXA1 SRX1161188 | ZR-75-1 Breast | 283 / 16536 (1.7%) | 9374 / 165360 (5.7%) | −134.3 | −132.3 | 0.30 |
| FOXA1 SRX3923533 | ZR-75-1 Breast | 431 / 16536 (2.6%) | 11748 / 165360 (7.1%) | −134.1 | −132.1 | 0.37 |
| Epitope tags SRX11470534 | Mesenchymal stem cells Others | 710 / 16536 (4.3%) | 15850 / 165360 (9.6%) | −133.9 | −132.0 | 0.45 |
| Epitope tags SRX2745846 | MCF 10A Breast | 248 / 16536 (1.5%) | 8762 / 165360 (5.3%) | −133.8 | −131.8 | 0.28 |
| EP300 SRX190219 | SK-N-SH Neural | 384 / 16536 (2.3%) | 11000 / 165360 (6.7%) | −133.8 | −131.8 | 0.35 |
| FOXA1 SRX15430993 | SK-BR-3 Breast | 362 / 16536 (2.2%) | 10649 / 165360 (6.4%) | −133.7 | −131.8 | 0.34 |
| FOXA1 SRX11222442 | MCF-7 Breast | 266 / 16536 (1.6%) | 9060 / 165360 (5.5%) | −133.6 | −131.6 | 0.29 |
| FOXA1 SRX11222438 | MCF-7 Breast | 209 / 16536 (1.3%) | 8066 / 165360 (4.9%) | −133.6 | −131.6 | 0.26 |
| FOXA1 SRX5203307 | MCF-7 Breast | 110 / 16536 (0.7%) | 6166 / 165360 (3.7%) | −133.5 | −131.6 | 0.18 |
| ELF3 SRX825394 | CFPAC-1 Pancreas | 639 / 16536 (3.9%) | 14820 / 165360 (9.0%) | −133.4 | −131.5 | 0.43 |
| FOXA1 SRX3931033 | MCF-7 Breast | 251 / 16536 (1.5%) | 8799 / 165360 (5.3%) | −133.4 | −131.5 | 0.29 |
| ESR1 SRX2943589 | MCF-7 Breast | 202 / 16536 (1.2%) | 7933 / 165360 (4.8%) | −133.4 | −131.5 | 0.25 |
| FOXA1 SRX1161191 | ZR-75-1 Breast | 321 / 16536 (1.9%) | 9972 / 165360 (6.0%) | −133.3 | −131.3 | 0.32 |
| DNA-RNA hybrid SRX20083265 | SH-SY5Y Neural | 703 / 16536 (4.3%) | 2156 / 165360 (1.3%) | −133.3 | −131.3 | 3.26 |
| DLX5 SRX17306262 | Trophoblast stem cells Placenta | 476 / 16536 (2.9%) | 12410 / 165360 (7.5%) | −133.3 | −131.3 | 0.38 |
| CREBBP SRX359409 | 293 Kidney | 1484 / 16536 (9.0%) | 7075 / 165360 (4.3%) | −133.1 | −131.2 | 2.10 |
| NKX2-1 SRX366169 | NCI-H441 Lung | 480 / 16536 (2.9%) | 12461 / 165360 (7.5%) | −133.1 | −131.1 | 0.39 |
| SS18 SRX10640841 | SK-MEL-147 Epidermis | 564 / 16536 (3.4%) | 13714 / 165360 (8.3%) | −133.0 | −131.1 | 0.41 |
| TP53 SRX19538269 | U2OS Bone | 338 / 16536 (2.0%) | 484 / 165360 (0.3%) | −132.7 | −130.8 | 6.98 |
| MED1 SRX4937338 | HCT 116 Digestive tract | 1313 / 16536 (7.9%) | 5916 / 165360 (3.6%) | −132.7 | −130.7 | 2.22 |
| Epitope tags SRX8030771 | 293 Kidney | 1514 / 16536 (9.2%) | 7294 / 165360 (4.4%) | −132.6 | −130.6 | 2.08 |
| TEAD1 SRX1011298 | HuCCT1 Liver | 155 / 16536 (0.9%) | 7033 / 165360 (4.3%) | −132.5 | −130.6 | 0.22 |
| FOXA2 SRX3230382 | Hep G2 Liver | 546 / 16536 (3.3%) | 13425 / 165360 (8.1%) | −132.4 | −130.4 | 0.41 |
| EP300 SRX2194266 | SUM 159PT Breast | 688 / 16536 (4.2%) | 15475 / 165360 (9.4%) | −132.3 | −130.4 | 0.44 |
| NFIC SRX190336 | SK-N-SH Neural | 556 / 16536 (3.4%) | 13570 / 165360 (8.2%) | −132.3 | −130.4 | 0.41 |
| CBFB SRX265218 | ME-1 Blood | 1374 / 16536 (8.3%) | 6337 / 165360 (3.8%) | −132.3 | −130.4 | 2.17 |
| ARID1A SRX5089388 | MCF-7 Breast | 201 / 16536 (1.2%) | 7877 / 165360 (4.8%) | −132.1 | −130.2 | 0.26 |
| SMARCA4 SRX8588623 | Pulmonary artery endothelial cells Cardiovascular | 562 / 16536 (3.4%) | 13647 / 165360 (8.3%) | −132.1 | −130.2 | 0.41 |
| CEBPB SRX190345 | MCF-7 Breast | 308 / 16536 (1.9%) | 9699 / 165360 (5.9%) | −131.6 | −129.7 | 0.32 |
| FOXA1 SRX3923516 | MCF-7 Breast | 291 / 16536 (1.8%) | 9415 / 165360 (5.7%) | −131.6 | −129.6 | 0.31 |
| RBFOX2 SRX4708034 | Hep G2 Liver | 1760 / 16536 (10.6%) | 9080 / 165360 (5.5%) | −131.4 | −129.5 | 1.94 |
| PHF6 SRX11508322 | G-401 Kidney | 840 / 16536 (5.1%) | 2950 / 165360 (1.8%) | −131.3 | −129.4 | 2.85 |
| ESR1 SRX330067 | MCF-7 Breast | 371 / 16536 (2.2%) | 10703 / 165360 (6.5%) | −131.1 | −129.2 | 0.35 |
| CDK9 SRX10131663 | Bronchial tracheal epithelial cells Lung | 996 / 16536 (6.0%) | 3894 / 165360 (2.4%) | −131.1 | −129.2 | 2.56 |
| WAS SRX5371250 | GM11518 Blood | 1030 / 16536 (6.2%) | 4110 / 165360 (2.5%) | −130.9 | −128.9 | 2.51 |
| Epitope tags SRX15725650 | 293 Kidney | 1524 / 16536 (9.2%) | 7410 / 165360 (4.5%) | −130.7 | −128.8 | 2.06 |
| STAT3 SRX2020842 | HCC70 Breast | 718 / 16536 (4.3%) | 15829 / 165360 (9.6%) | −130.6 | −128.7 | 0.45 |
| TEAD1 SRX7807114 | Unclassified Unclassified | 200 / 16536 (1.2%) | 7800 / 165360 (4.7%) | −130.3 | −128.4 | 0.26 |
| VGLL1 SRX18013277 | FULVR Breast | 170 / 16536 (1.0%) | 7246 / 165360 (4.4%) | −130.2 | −128.3 | 0.23 |
| Epitope tags SRX11470532 | Mesenchymal stem cells Others | 531 / 16536 (3.2%) | 13114 / 165360 (7.9%) | −130.1 | −128.2 | 0.40 |
| BCORL1 SRX10184497 | K-562 Blood | 1874 / 16536 (11.3%) | 9951 / 165360 (6.0%) | −130.0 | −128.1 | 1.88 |
| GFP SRX6949256 | HeLa Uterus | 443 / 16536 (2.7%) | 11778 / 165360 (7.1%) | −129.8 | −127.9 | 0.38 |
| JADE3 DRX300415 | 293 Kidney | 1393 / 16536 (8.4%) | 6522 / 165360 (3.9%) | −129.7 | −127.8 | 2.14 |
| WWTR1 SRX10119368 | MCF 10A Breast | 279 / 16536 (1.7%) | 9148 / 165360 (5.5%) | −129.5 | −127.6 | 0.30 |
| FOSL1 SRX17608312 | T24 Others | 147 / 16536 (0.9%) | 6791 / 165360 (4.1%) | −129.5 | −127.6 | 0.22 |
| KDM1A SRX10637290 | MDA-MB-231 Breast | 518 / 16536 (3.1%) | 12890 / 165360 (7.8%) | −129.3 | −127.4 | 0.40 |
| FOXA1 SRX3923518 | MCF-7 Breast | 278 / 16536 (1.7%) | 9121 / 165360 (5.5%) | −129.3 | −127.4 | 0.30 |
| KAT6A SRX20971022 | Fibroblasts Others | 201 / 16536 (1.2%) | 107 / 165360 (0.1%) | −129.1 | −127.2 | 18.79 |
| FOS SRX3322637 | MCF-7 Breast | 211 / 16536 (1.3%) | 7959 / 165360 (4.8%) | −129.1 | −127.2 | 0.27 |
| DNA-RNA hybrid SRX21658481 | U2OS Bone | 554 / 16536 (3.4%) | 1435 / 165360 (0.9%) | −128.9 | −127.0 | 3.86 |
| Epitope tags SRX8080558 | Mammary gland adenocarcinoma Breast | 145 / 16536 (0.9%) | 6736 / 165360 (4.1%) | −128.9 | −127.0 | 0.22 |
| ZNF711 SRX7805362 | 293 Kidney | 1345 / 16536 (8.1%) | 6213 / 165360 (3.8%) | −128.8 | −126.9 | 2.16 |
| NANOG SRX3288567 | hESC H9 Pluripotent stem cell | 138 / 16536 (0.8%) | 6585 / 165360 (4.0%) | −128.6 | −126.7 | 0.21 |
| FOXA1 SRX5203294 | MCF-7 Breast | 112 / 16536 (0.7%) | 6067 / 165360 (3.7%) | −128.5 | −126.6 | 0.18 |
| ESR1 SRX1012632 | MCF-7 Breast | 205 / 16536 (1.2%) | 7809 / 165360 (4.7%) | −127.7 | −125.8 | 0.26 |
| NR3C1 SRX2609666 | HASM2 Lung | 398 / 16536 (2.4%) | 11004 / 165360 (6.7%) | −127.7 | −125.8 | 0.36 |
| ESR1 SRX20282955 | MCF-7 Breast | 449 / 16536 (2.7%) | 11766 / 165360 (7.1%) | −127.1 | −125.2 | 0.38 |
| ESR1 SRX3123829 | MCF-7 Breast | 243 / 16536 (1.5%) | 8455 / 165360 (5.1%) | −127.0 | −125.1 | 0.29 |
| TLE3 SRX4815194 | SUM 149PT Breast | 314 / 16536 (1.9%) | 9639 / 165360 (5.8%) | −127.0 | −125.1 | 0.33 |
| ESR1 SRX20282973 | MCF-7 Breast | 512 / 16536 (3.1%) | 12712 / 165360 (7.7%) | −127.0 | −125.1 | 0.40 |
| ARID1A SRX5089391 | MCF-7 Breast | 231 / 16536 (1.4%) | 8245 / 165360 (5.0%) | −126.9 | −125.1 | 0.28 |
| ESR1 SRX330070 | MCF-7 Breast | 220 / 16536 (1.3%) | 8045 / 165360 (4.9%) | −126.7 | −124.9 | 0.27 |
| ESR1 SRX8537722 | MCF-7 Breast | 387 / 16536 (2.3%) | 10798 / 165360 (6.5%) | −126.7 | −124.8 | 0.36 |
| HOXC5 SRX2731653 | PC-3 Prostate | 327 / 16536 (2.0%) | 9843 / 165360 (6.0%) | −126.6 | −124.8 | 0.33 |
| BCORL1 SRX10184496 | K-562 Blood | 1834 / 16536 (11.1%) | 9756 / 165360 (5.9%) | −126.5 | −124.6 | 1.88 |
| NR2F2 SRX190293 | MCF-7 Breast | 445 / 16536 (2.7%) | 11688 / 165360 (7.1%) | −126.5 | −124.6 | 0.38 |
| JUNB SRX10119385 | MCF 10A Breast | 182 / 16536 (1.1%) | 7355 / 165360 (4.4%) | −126.5 | −124.6 | 0.25 |
| DDIT3 SRX11379509 | Liposarcoma, Myxoid Adipocyte | 302 / 16536 (1.8%) | 9422 / 165360 (5.7%) | −126.4 | −124.5 | 0.32 |
| ESR1 SRX1531796 | MCF-7 Breast | 224 / 16536 (1.4%) | 8097 / 165360 (4.9%) | −126.3 | −124.4 | 0.28 |
| KMT2B DRX059614 | HB1119 Blood | 813 / 16536 (4.9%) | 2874 / 165360 (1.7%) | −125.8 | −123.9 | 2.83 |
| FOSL1 SRX190212 | HCT 116 Digestive tract | 467 / 16536 (2.8%) | 11993 / 165360 (7.3%) | −125.7 | −123.9 | 0.39 |
| ESR1 SRX20282940 | MCF-7 Breast | 464 / 16536 (2.8%) | 11947 / 165360 (7.2%) | −125.7 | −123.8 | 0.39 |
| EP300 SRX10976215 | A549 Lung | 377 / 16536 (2.3%) | 10603 / 165360 (6.4%) | −125.7 | −123.8 | 0.36 |
| EP300 SRX1012648 | MCF-7 Breast | 200 / 16536 (1.2%) | 7652 / 165360 (4.6%) | −125.6 | −123.8 | 0.26 |
| ESR1 SRX10365534 | MCF-7 Breast | 122 / 16536 (0.7%) | 6182 / 165360 (3.7%) | −125.6 | −123.7 | 0.20 |
| WWTR1 SRX10119390 | MDA-MB-231 Breast | 144 / 16536 (0.9%) | 6615 / 165360 (4.0%) | −125.5 | −123.6 | 0.22 |
| ZEB1 SRX13298924 | MCF-7 Breast | 202 / 16536 (1.2%) | 7677 / 165360 (4.6%) | −125.2 | −123.4 | 0.26 |
| ESR1 SRX10365533 | MCF-7 Breast | 202 / 16536 (1.2%) | 7678 / 165360 (4.6%) | −125.2 | −123.4 | 0.26 |
| FOXA1 SRX3923517 | MCF-7 Breast | 299 / 16536 (1.8%) | 9332 / 165360 (5.6%) | −125.2 | −123.3 | 0.32 |
| ELF3 SRX1389380 | CFPAC-1 Pancreas | 482 / 16536 (2.9%) | 12191 / 165360 (7.4%) | −125.1 | −123.2 | 0.40 |
| JUN SRX699737 | HCASMC Cardiovascular | 264 / 16536 (1.6%) | 8745 / 165360 (5.3%) | −125.1 | −123.2 | 0.30 |
| FOXA1 SRX1447317 | MCF-7 Breast | 273 / 16536 (1.7%) | 8896 / 165360 (5.4%) | −124.9 | −123.1 | 0.31 |
| ZNF711 SRX7805363 | 293 Kidney | 1398 / 16536 (8.5%) | 6668 / 165360 (4.0%) | −124.9 | −123.0 | 2.10 |
| NR3C1 SRX19024866 | MCF-7 Breast | 145 / 16536 (0.9%) | 6613 / 165360 (4.0%) | −124.8 | −123.0 | 0.22 |
| G3BP1 SRX24196609 | KGN Gonad | 1493 / 16536 (9.0%) | 7338 / 165360 (4.4%) | −124.7 | −122.8 | 2.03 |
| FOXA1 SRX1389379 | CFPAC-1 Pancreas | 275 / 16536 (1.7%) | 8914 / 165360 (5.4%) | −124.6 | −122.8 | 0.31 |
| ESR1 SRX1161185 | ZR-75-1 Breast | 209 / 16536 (1.3%) | 7779 / 165360 (4.7%) | −124.6 | −122.7 | 0.27 |
| ESR1 SRX8537723 | MCF-7 Breast | 339 / 16536 (2.1%) | 9961 / 165360 (6.0%) | −124.5 | −122.6 | 0.34 |
| FOXA1 SRX3923529 | ZR-75-1 Breast | 392 / 16536 (2.4%) | 10793 / 165360 (6.5%) | −124.4 | −122.5 | 0.36 |
| RNF2 SRX18954719 | SCC-25 Others | 557 / 16536 (3.4%) | 13269 / 165360 (8.0%) | −124.2 | −122.3 | 0.42 |
| ESR1 SRX4451213 | MCF-7 Breast | 430 / 16536 (2.6%) | 11367 / 165360 (6.9%) | −124.1 | −122.2 | 0.38 |
| FOXA1 SRX028635 | MCF-7 Breast | 211 / 16536 (1.3%) | 7799 / 165360 (4.7%) | −124.0 | −122.2 | 0.27 |
| FOXA1 SRX1161203 | T-47D Breast | 305 / 16536 (1.8%) | 9393 / 165360 (5.7%) | −124.0 | −122.1 | 0.32 |
| ESR1 SRX330068 | MCF-7 Breast | 202 / 16536 (1.2%) | 7631 / 165360 (4.6%) | −123.8 | −121.9 | 0.26 |
| KMT2A SRX2281247 | SEM Blood | 1493 / 16536 (9.0%) | 7361 / 165360 (4.5%) | −123.7 | −121.9 | 2.03 |
| CEBPA SRX2630241 | Hep G2 Liver | 511 / 16536 (3.1%) | 12573 / 165360 (7.6%) | −123.7 | −121.8 | 0.41 |
| ESR1 SRX1469949 | MCF-7 Breast | 246 / 16536 (1.5%) | 8396 / 165360 (5.1%) | −123.7 | −121.8 | 0.29 |
| PGR SRX1012655 | MCF-7 Breast | 275 / 16536 (1.7%) | 8883 / 165360 (5.4%) | −123.6 | −121.8 | 0.31 |
| FOXA1 SRX3931056 | MCF-7 Breast | 245 / 16536 (1.5%) | 8376 / 165360 (5.1%) | −123.6 | −121.7 | 0.29 |
| BRD4 SRX736204 | 90-8TL Neural | 801 / 16536 (4.8%) | 2838 / 165360 (1.7%) | −123.5 | −121.7 | 2.82 |
| ESR1 SRX3110725 | MCF-7 Breast | 382 / 16536 (2.3%) | 10600 / 165360 (6.4%) | −123.4 | −121.6 | 0.36 |
| ESR1 SRX2881000 | MCF-7 Breast | 378 / 16536 (2.3%) | 10535 / 165360 (6.4%) | −123.3 | −121.4 | 0.36 |
| SP1 SRX190269 | A549 Lung | 592 / 16536 (3.6%) | 13737 / 165360 (8.3%) | −123.2 | −121.4 | 0.43 |
| FOXA1 SRX3931032 | MCF-7 Breast | 244 / 16536 (1.5%) | 8341 / 165360 (5.0%) | −123.0 | −121.2 | 0.29 |
| NABP2 SRX9523535 | HT-1080 Bone | 1240 / 16536 (7.5%) | 5629 / 165360 (3.4%) | −123.0 | −121.1 | 2.20 |
| YAP1 SRX1038944 | IMR-90 Lung | 157 / 16536 (0.9%) | 6782 / 165360 (4.1%) | −122.9 | −121.0 | 0.23 |
| GFP SRX5417098 | HeLa Uterus | 484 / 16536 (2.9%) | 12136 / 165360 (7.3%) | −122.8 | −121.0 | 0.40 |
| AR SRX9469988 | LAPC-4 Prostate | 568 / 16536 (3.4%) | 13373 / 165360 (8.1%) | −122.7 | −120.9 | 0.42 |
| SMARCA4 SRX5982340 | A549 Lung | 165 / 16536 (1.0%) | 6925 / 165360 (4.2%) | −122.7 | −120.8 | 0.24 |
| KAT7 DRX234808 | 293 Kidney | 702 / 16536 (4.2%) | 2289 / 165360 (1.4%) | −122.3 | −120.5 | 3.07 |
| FOXA2 SRX6441751 | CFPAC-1 Pancreas | 185 / 16536 (1.1%) | 7279 / 165360 (4.4%) | −122.3 | −120.5 | 0.25 |
| GATA3 SRX6712581 | MCF-7 Breast | 352 / 16536 (2.1%) | 10086 / 165360 (6.1%) | −122.2 | −120.3 | 0.35 |
| FOXA1 SRX3923528 | ZR-75-1 Breast | 287 / 16536 (1.7%) | 9032 / 165360 (5.5%) | −122.1 | −120.3 | 0.32 |
| NR3C1 SRX8520809 | SUM 159PT Breast | 373 / 16536 (2.3%) | 10415 / 165360 (6.3%) | −122.1 | −120.3 | 0.36 |
| KAT6B DRX411444 | 293 Kidney | 1921 / 16536 (11.6%) | 10533 / 165360 (6.4%) | −122.0 | −120.2 | 1.82 |
| KMT2A SRX1293531 | MV-4-11 Blood | 2295 / 16536 (13.9%) | 13406 / 165360 (8.1%) | −121.9 | −120.0 | 1.71 |
| ESR1 SRX20282971 | MCF-7 Breast | 427 / 16536 (2.6%) | 11239 / 165360 (6.8%) | −121.8 | −120.0 | 0.38 |
| ESR1 SRX1012629 | MCF-7 Breast | 275 / 16536 (1.7%) | 8824 / 165360 (5.3%) | −121.8 | −120.0 | 0.31 |
| FOXA1 SRX8083099 | CAMA-1 Breast | 402 / 16536 (2.4%) | 10853 / 165360 (6.6%) | −121.8 | −120.0 | 0.37 |
| KAT6B DRX411443 | 293 Kidney | 1945 / 16536 (11.8%) | 10721 / 165360 (6.5%) | −121.7 | −119.9 | 1.81 |
| TP53 SRX19538270 | U2OS Bone | 319 / 16536 (1.9%) | 476 / 165360 (0.3%) | −121.7 | −119.9 | 6.70 |
| RELA SRX7054617 | HAEC Cardiovascular | 499 / 16536 (3.0%) | 12317 / 165360 (7.4%) | −121.7 | −119.9 | 0.41 |
| BCORL1 SRX10184498 | K-562 Blood | 1898 / 16536 (11.5%) | 10371 / 165360 (6.3%) | −121.7 | −119.9 | 1.83 |
| EP300 SRX22550927 | CDS1 Bone | 632 / 16536 (3.8%) | 14245 / 165360 (8.6%) | −121.6 | −119.8 | 0.44 |
| NANOG SRX10445309 | Neural crest cells Neural | 230 / 16536 (1.4%) | 8054 / 165360 (4.9%) | −121.6 | −119.8 | 0.29 |
| ARID1A SRX5089382 | MCF-7 Breast | 302 / 16536 (1.8%) | 9261 / 165360 (5.6%) | −121.6 | −119.7 | 0.33 |
| ESR1 SRX4451212 | MCF-7 Breast | 403 / 16536 (2.4%) | 10852 / 165360 (6.6%) | −121.3 | −119.4 | 0.37 |
| ESR1 SRX2881002 | MCF-7 Breast | 411 / 16536 (2.5%) | 10971 / 165360 (6.6%) | −121.2 | −119.4 | 0.37 |
| FOS SRX7760064 | CFPAC-1 Pancreas | 339 / 16536 (2.1%) | 9838 / 165360 (5.9%) | −121.0 | −119.2 | 0.34 |
| BRD4 SRX612504 | LX2 Liver | 197 / 16536 (1.2%) | 7454 / 165360 (4.5%) | −121.0 | −119.2 | 0.26 |
| CEBPB SRX1027438 | Mesenchymal stem cells Others | 542 / 16536 (3.3%) | 12924 / 165360 (7.8%) | −121.0 | −119.2 | 0.42 |
| KDM5B SRX3285611 | MCF-7 Breast | 1131 / 16536 (6.8%) | 4944 / 165360 (3.0%) | −121.0 | −119.2 | 2.29 |
| RELA SRX7054657 | HAEC Cardiovascular | 471 / 16536 (2.8%) | 11869 / 165360 (7.2%) | −120.9 | −119.0 | 0.40 |
| Epitope tags SRX4192708 | MDA-MB-231 Breast | 942 / 16536 (5.7%) | 3734 / 165360 (2.3%) | −120.9 | −119.0 | 2.52 |
Showing first 500 of 18564 rows.